Infarction, Middle Cerebral Artery Clinical Trial
Official title:
Evaluation of Safety, Feasibility and Treatment Potential for Old Stroke Patients Using Intracerebral Implantation of Olfactory Ensheathing Cells
Recruited patients should receive the endoscopic surgery for picking the olfactory mucosa 1 to 2 months before transplantation. The Olfactory Ensheathing Cells (OECs) will be cultured and expanded under the rule of GTP. Then, quality control of OECs should be done by immunohistochemical staining positive for GFAP, S100, and P75. Finally, the investigators will transplant the OECs (about 2 to 8 X 10´6 cells in saline) into the peri-infarcted area of the brain.
(1)Recruited patients should receive the endoscopic surgery for picking the olfactory mucosa 1 to 2 months before transplantation. The OECs will be cultured and expanded under the rule of GTP. Then, quality control of OECs should be done by immunohistochemical staining positive for GFAP, S100, and P75. Finally, the investigators will transplanted the OECs (about 2 to 8 X 10´6 cells in saline) into the peri-infarcted area of the brain. (2) Combination with traditional drug therapy (such as used the anti-thrombosis reagent or anti-platelet aggregation reagent). (3) NIH-stroke scale (NIHSS), European stroke scale (ESS), European stroke motor subscale (EMS), Barthel Index(BI) and MMSE will be performed for each patient to evaluate the therapeutic effect as the primary end points. (4) In addition, MRI(DTI) & TMS(MEP) will be also checked for each recruitment patient as the secondary end points. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02016547 -
Thrombectomy Under Reopro Versus Alteplase to Treat Stoke
|
Phase 4 | |
Completed |
NCT00761982 -
Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.
|
Phase 1/Phase 2 | |
Completed |
NCT00535197 -
Autologous Bone Marrow Stem Cells in Ischemic Stroke.
|
Phase 1/Phase 2 | |
Recruiting |
NCT05899582 -
Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial
|
N/A | |
Completed |
NCT01468064 -
Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke
|
Phase 1/Phase 2 | |
Completed |
NCT04292600 -
Testing of Identification Markers for Stroke
|
||
Suspended |
NCT03098732 -
Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS) Trial
|
N/A | |
Completed |
NCT01113645 -
Impact of Cranioplasty On Cerebral Perfusion
|
N/A | |
Completed |
NCT03679364 -
An Observational Registry Study of LUOTAI in Patients With Acute Ischemic Stroke in Vietnam
|
||
Not yet recruiting |
NCT01438593 -
Study of Purified Umbilical Cord Blood CD34+ Stem Cell on Chronic Ischemic Stroke
|
Phase 1 | |
Completed |
NCT02594137 -
A Comparison Between Two Techniques for Performing Decompressive Craniectomy
|
N/A | |
Completed |
NCT00604630 -
Multicenter Efficacy Study of Recombinant Human Erythropoietin in Acute Ischemic Stroke
|
Phase 2/Phase 3 | |
Recruiting |
NCT04093336 -
Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients
|
Phase 1/Phase 2 | |
Completed |
NCT00473057 -
Study of Autologous Stem Cell Transplantation for Patients With Ischemic Stroke
|
Phase 1 |